查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1659439

全球粒子治疗市场

Particle Therapy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 83 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球粒子治疗市场规模将达到 28 亿美元

2024 年全球粒子束治疗市场规模估计为 17 亿美元，预计到 2030 年将达到 28 亿美元，2024 年至 2030 年的复合年增长率为 8.8%。质子治疗是报告中分析的一个领域，预计到分析期结束时复合年增长率为 9.2%，达到 23 亿美元。在分析期内，重离子治疗领域预计将以 7.1% 的复合年增长率成长。

美国市场规模估计为 4.814 亿美元，中国市场预计复合年增长率为 8.0%

预计2024年美国粒子治疗市值将达4.814亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 4.321 亿美元，在 2024 年至 2030 年的分析期内，复合年增长率为 8.0%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 8.3% 和 7.0%。在欧洲，预计德国的复合年增长率约为 7.0%。

全球粒子治疗市场-主要趋势与驱动因素摘要

为什么粒子束疗法对于现代癌症治疗至关重要？

粒子治疗提供精确、有针对性的放射治疗，同时最大限度地减少对周围健康组织的损害，使其成为现代癌症治疗中必不可少且高效的治疗选择。与传统的基于光子的辐射不同，粒子疗法使用带电粒子，例如质子或碳离子，使肿瘤学家能够将高剂量的辐射直接传送到肿瘤，同时保护相邻的健康组织。这种精确度在治疗靠近重要结构的癌症时尤其有价值，例如脑肿瘤、儿童癌症或脊髓附近的肿瘤，因为保留健康组织至关重要。因此，粒子治疗已成为治疗复杂难治癌症的基石，显着改善了治疗效果并减少了副作用。

除了精确度之外，粒子疗法还能在肿瘤部位提供高剂量强度，这使其对不太可能对常规放射治疗产生反应的放射抗性肿瘤特别有效。粒子束的独特性质，例如布拉格峰效应，可将最大能量直接传送到肿瘤部位，从而减少肿瘤外的辐射暴露。这一优势有助于最大限度地减少副作用和长期併发症，这对于儿科患者和癌症位于敏感器官附近的患者尤其有益。对于患者来说，粒子治疗意味着更少的併发症和更短的治疗时间，使其成为现代肿瘤学精准癌症治疗的首选。

此外，粒子治疗可以根据每个患者肿瘤的特征制定治疗计划，从而适应个人化癌症治疗的趋势。影像和治疗计划的进步使得肿瘤学家能够使用粒子疗法根据肿瘤的大小、形状和位置以无与伦比的精度瞄准肿瘤，提供改善治疗效果的个人化治疗方法。这种能力使粒子治疗成为精准肿瘤学的重要组成部分，有助于满足高度标靶治疗需求，改善患者治疗效果，同时减轻癌症治疗带来的身体和心理负担。

科技进步如何增强粒子疗法？

技术进步显着提高了粒子治疗的有效性、可近性和效率，扩大了其在癌症治疗中的应用和吸引力。该领域最重要的创新之一是调变质子治疗 (IMPT) 的发展，它可以实现更高的剂量分布精度。 IMPT 允许肿瘤学家调整质子束的强度，使他们能够更精确地将其塑造成肿瘤的轮廓并更有效地保护附近的健康组织。这种高度的控制降低了放射引起的副作用的风险，对于复杂和形状不规则的肿瘤尤其有益。随着 IMPT 技术的不断进步，它正在改善具有挑战性的癌症类型的患者的治疗效果并提高粒子治疗的整体效果。

即时MRI和PET扫描等先进影像技术的整合，透过提供详细的即时影像来指南治疗，进一步提高了粒子治疗的精准度。这些影像技术使肿瘤学家能够精确定位肿瘤的位置，并根据肿瘤的运动（例如呼吸或患者的运动）调整治疗参数。将即时成像与粒子疗法结合，可以帮助肿瘤学家提供更精确、更适应的治疗，确保辐射到达肿瘤，同时保护周围组织。这项创新支持自适应粒子治疗，允许随着肿瘤对治疗的反应变化而动态调整治疗，从而提高疗效并最大限度地减少副作用。

单室质子治疗设备等紧凑、经济高效的粒子治疗系统的发展提高了粒子治疗的可及性和可负担性。传统上，粒子束治疗需要大型、复杂且昂贵的设施，而且全球只有少数人能够使用这些设施。然而，小型化系统的进步使得更多的医院和癌症中心能够采用粒子治疗技术，使更多的患者能够使用这种技术。这些紧凑的系统减少了对广泛基础设施的需求，大大降低了成本，并使当地医院和区域癌症中心能够提供这种先进的治疗。透过使粒子疗法更加经济实惠且更广泛地应用，这些技术进步将扩大其覆盖范围并为更多患者带来精准的癌症治疗。

粒子治疗对病人和医疗保健系统有哪些益处？

粒子疗法为癌症治疗提供了一种精确、有效且对患者友好的方法，为患者和医疗保健系统带来了显着的益处。对于患者来说，粒子疗法的主要优点之一是它最大限度地减少了对健康组织的损害并减少了短期和长期的副作用。这种组织保护特性对于儿科患者和肿瘤位于精细结构附近的患者尤其有价值，因为它可以降低併发症的风险并维持生活品质。粒子束治疗可最大限度地减少周围组织的放射线暴露，使治疗的副作用更少，从而加快恢復速度并改善治疗后的生活品质。这种益处对于年轻患者尤其有益，因为它可以降低与辐射暴露相关的继发性癌症和发育问题的风险。

对于医疗保健系统来说，粒子疗法降低了与管理放射相关副作用和併发症相关的长期照护成本。传统放射治疗通常需要大量的治疗后护理来控制放射性皮肤炎、器官损伤甚至继发性恶性肿瘤等副作用。粒子治疗的精确定位显着降低了这些併发症的发生率，从而减少了住院时间并减少了后续治疗的需要。治疗后併发症的减少意味着医疗保健系统的成本节省，并允许更有效地分配资源。透过支持更好的患者治疗结果和更少的长期影响，粒子疗法有助于更永续治疗癌症，并为医疗保健系统带来财务和营运效益。

粒子疗法也符合个人化、精准肿瘤治疗的转变，使医疗保健提供者能够根据每位患者肿瘤的特征制定治疗方案。先进的影像和治疗计划技术使肿瘤学家能够根据肿瘤的位置、大小和形状制定个人化的粒子治疗通讯协定。这种个人化治疗可以让患者接受所需的确切辐射量，而不会受到不必要的暴露，从而提高治疗效果并优化资源利用。对于医疗保健系统而言，个人化护理的能力将提高患者的满意度和治疗效果，从而提高粒子疗法作为综合癌症治疗计划的一部分的价值。粒子束治疗对患者和医疗保健提供者的变革潜力是巨大的：改善生活质量，降低长期成本并支持精准癌症治疗。

推动粒子治疗市场成长的因素是什么？

粒子束治疗市场的成长受到癌症发病率上升、对微创和精准癌症治疗的需求增加、粒子束治疗技术的进步以及质子和碳离子治疗中心的扩大等因素的推动。随着全球癌症发生率持续上升，迫切需要先进的治疗方案来改善治疗效果并最大限度地减少副作用。粒子疗法透过精确瞄准和减少对健康组织的影响，为传统放射疗法提供了一种有效且对患者友好的治疗方法，从而满足了这一需求。这种需求在儿科肿瘤学中尤其强烈，因为该领域最需要保留组织的治疗。随着全球癌症发病率的不断上升，对粒子束治疗等高精度治疗的需求预计将推动市场扩张。

对微创癌症治疗的需求不断增长，进一步推动了粒子束治疗市场的成长。患者和医疗保健提供者都在寻求能够产生有效结果、副作用更少、恢復时间更短的治疗方法。粒子治疗透过将高剂量的辐射直接传送到肿瘤同时保留周围组织来满足精确度和微创性的要求。粒子疗法相对于传统放射疗法的优势越来越被患者和医疗保健专业人士所认可，从而导致采用率不断提高。随着患者寻求平衡疗效和生活品质的治疗方法，粒子束治疗正在成为治疗复杂、高风险癌症的合适选择。

此外，粒子治疗技术的进步，例如粒子治疗装置的小型化和单室系统，也使得粒子治疗更加方便且经济实惠，从而进一步推动市场成长。这些紧凑的系统减少了传统粒子治疗设施所需的基础设施和成本，使更多医院和癌症中心能够采用这种先进技术。此外，强度调变质子治疗和自适应治疗计划等创新使粒子治疗更加精确、适应性更强，从而能够更有效地治疗更多种癌症类型。随着技术的不断进步，粒子疗法将在更广泛的医疗机构中得到应用，扩大患者治疗机会并推动市场成长。

粒子束治疗中心的扩张，特别是在北美、欧洲和亚太等地区，也是推动市场成长的主要因素。世界各国政府和医疗保健组织都在投资粒子治疗基础设施，认识到其在癌症治疗方面的好处以及降低长期医疗成本的潜力。此外，许多国家也提供报销和财政援助，以使患者更容易接受粒子治疗。随着全球范围内越来越多的粒子治疗中心的建立，这种治疗方法的可用性和认知度正在提高，从而推动了进一步的需求。这些因素的结合——癌症发病率的上升、精准治疗的需求、技术进步和基础设施的不断扩大——导致了粒子治疗市场的强劲增长，使其成为现代肿瘤学和个人化癌症治疗的关键组成部分。

部分

种类（质子治疗、重粒子治疗）；系统（多室系统、单室系统）；用途（治疗、研究）

受访公司范例（22家值得关注的公司）

  • Accuray Incorporated
  • Advanced Oncotherapy
  • Brainlab
  • Danfysik A/S
  • Elekta AB
  • Hitachi Ltd.
  • IBA Worldwide
  • Koninklijke Philips NV
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • Optivus Proton Therapy Inc.
  • Panacea
  • ProTom International
  • Provision Healthcare
  • PTW Freiburg GmbH
  • SAH Global LLC
  • Shinva Medical Instrument Co. Ltd
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems Inc.
  • xstrahl

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP22463

Global Particle Therapy Market to Reach US$2.8 Billion by 2030

The global market for Particle Therapy estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Heavy Ion Therapy segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$481.4 Million While China is Forecast to Grow at 8.0% CAGR

The Particle Therapy market in the U.S. is estimated at US$481.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$432.1 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.3% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.

Global Particle Therapy Market - Key Trends & Drivers Summarized

Why Is Particle Therapy Essential in Modern Cancer Treatment?

Particle therapy has become an essential and highly effective treatment option in modern cancer care, providing precise, targeted radiation therapy with minimal damage to surrounding healthy tissue. Unlike traditional photon-based radiation, particle therapy uses charged particles like protons and carbon ions, which allow oncologists to deliver a high dose of radiation directly to tumors while sparing adjacent healthy tissues. This precision is particularly valuable in treating cancers located near critical structures, such as brain tumors, pediatric cancers, and tumors near the spinal cord, where preserving healthy tissue is crucial. As a result, particle therapy has become a cornerstone in the treatment of complex and hard-to-treat cancers, significantly improving outcomes and reducing side effects.

In addition to its accuracy, particle therapy offers a higher dose intensity at the tumor site, making it particularly effective for radioresistant tumors, which are less responsive to traditional forms of radiation. The unique properties of particle beams, such as the Bragg peak effect, allow them to release maximum energy directly at the tumor site, reducing radiation exposure beyond the tumor. This advantage minimizes side effects and long-term complications, which is especially beneficial for pediatric patients and those with cancers near sensitive organs. For patients, particle therapy means a potentially shorter treatment course with fewer complications, making it a preferred option in modern oncology for high-precision cancer care.

Moreover, particle therapy aligns with the growing trend of personalized cancer treatment, as it allows for treatment plans that are tailored to the unique characteristics of each patient’s tumor. With advancements in imaging and treatment planning, oncologists can use particle therapy to target tumors with unparalleled precision based on size, shape, and location, providing an individualized approach that improves treatment efficacy. This capability makes particle therapy an essential part of precision oncology, addressing the need for highly targeted treatments that enhance patient outcomes while reducing the physical and emotional burden of cancer treatment.

How Are Technological Advancements Enhancing Particle Therapy?

Technological advancements are significantly enhancing the effectiveness, accessibility, and efficiency of particle therapy, broadening its application and appeal in cancer treatment. One of the most significant innovations in this field is the development of intensity-modulated proton therapy (IMPT), which allows for even greater precision in dose distribution. IMPT enables oncologists to modulate the intensity of the proton beam, shaping it more accurately to match the tumor’s contours and sparing nearby healthy tissues even more effectively. This enhanced control reduces the risk of radiation-induced side effects and is particularly beneficial for complex, irregularly shaped tumors. As IMPT technology continues to advance, it offers improved outcomes for patients with challenging cancer types, increasing the overall effectiveness of particle therapy.

The integration of advanced imaging technologies, such as real-time MRI and PET scans, has further improved the accuracy of particle therapy by providing detailed, real-time images that guide treatment. These imaging technologies enable oncologists to precisely locate tumors and adjust treatment parameters to account for tumor movement, such as breathing or patient shifts, which is particularly important for tumors in the lungs or abdomen. By combining real-time imaging with particle therapy, oncologists can deliver more accurate and adaptive treatments, ensuring that radiation is consistently targeted to the tumor while sparing surrounding tissues. This innovation supports adaptive particle therapy, allowing treatment to be dynamically adjusted as the tumor changes in response to therapy, enhancing effectiveness and minimizing side effects.

The development of compact and cost-effective particle therapy systems, such as single-room proton therapy units, has increased the accessibility and affordability of particle therapy. Traditionally, particle therapy required large, complex, and expensive facilities, limiting its availability to a select number of centers worldwide. However, advancements in compact systems have made it possible for more hospitals and cancer centers to adopt particle therapy technology, making it accessible to a broader patient population. These compact systems reduce the need for large-scale infrastructure, significantly lowering costs and enabling community hospitals and regional cancer centers to offer this advanced treatment. By making particle therapy more affordable and widely available, these technological advancements are expanding its reach, providing more patients with access to high-precision cancer care.

What Are the Benefits of Particle Therapy for Patients and Healthcare Systems?

Particle therapy offers substantial benefits for both patients and healthcare systems, providing a precise, effective, and patient-friendly approach to cancer treatment. For patients, one of the primary advantages of particle therapy is its ability to minimize damage to healthy tissues, reducing both short-term and long-term side effects. This tissue-sparing property is particularly valuable for pediatric patients and those with tumors near sensitive structures, as it reduces the risk of complications and preserves quality of life. By minimizing radiation exposure to surrounding tissues, particle therapy allows patients to undergo treatment with fewer side effects, leading to a quicker recovery and enabling a better post-treatment quality of life. This advantage is especially beneficial for young patients, as it lowers the risk of secondary cancers and developmental issues associated with radiation exposure.

For healthcare systems, particle therapy reduces the long-term care costs associated with managing radiation-induced side effects and complications. Traditional radiation treatments often require extensive post-treatment care to manage side effects such as radiation dermatitis, damage to organs, and even secondary malignancies. With particle therapy’s precise targeting, the incidence of such complications is significantly reduced, leading to fewer hospital admissions and a lower demand for follow-up treatments. This reduction in post-treatment complications translates into cost savings for healthcare systems and allows resources to be allocated more effectively. By supporting better patient outcomes with fewer long-term effects, particle therapy contributes to a more sustainable approach to cancer care, which benefits healthcare systems financially and operationally.

Particle therapy also aligns well with the shift toward personalized and precision oncology, enabling healthcare providers to deliver treatments that are tailored to the unique characteristics of each patient’s tumor. With advanced imaging and treatment planning technologies, oncologists can develop individualized particle therapy protocols based on tumor location, size, and shape. This personalization enhances treatment efficacy and optimizes resource use, as patients receive precisely the amount of radiation needed without unnecessary exposure. For healthcare systems, the ability to provide tailored treatment improves patient satisfaction and outcomes, reinforcing the value of particle therapy as part of a comprehensive cancer care program. Together, these benefits—improved quality of life, reduced long-term costs, and support for precision oncology—highlight the transformative potential of particle therapy for patients and healthcare providers alike.

What Is Fueling the Growth in the Particle Therapy Market?

The growth in the particle therapy market is driven by factors such as the rising incidence of cancer, increasing demand for minimally invasive and precise cancer treatments, advancements in particle therapy technology, and expanded access to proton and carbon ion therapy centers. As cancer incidence continues to rise globally, there is an urgent demand for advanced treatment options that improve outcomes while minimizing side effects. Particle therapy, with its precise targeting and reduced impact on healthy tissues, meets this demand by providing an effective, patient-friendly alternative to traditional radiation. This demand is particularly strong in pediatric oncology, where the need for tissue-sparing therapies is paramount. As the global cancer burden grows, the demand for high-precision treatments like particle therapy is expected to drive market expansion.

The increasing demand for minimally invasive cancer treatments has further fueled growth in the particle therapy market. Patients and healthcare providers alike are seeking treatments that provide effective results with fewer side effects and shorter recovery times. Particle therapy, with its ability to deliver high-dose radiation directly to tumors while sparing surrounding tissues, aligns with this demand for precision and minimal invasiveness. The market is benefiting from a growing awareness among patients and providers about the advantages of particle therapy over traditional radiation, leading to higher adoption rates. As patients increasingly seek treatments that balance efficacy with quality of life, particle therapy is emerging as a preferred option for complex and high-risk cancers.

Advancements in particle therapy technology, such as compact and single-room systems, are also driving market growth by making particle therapy more accessible and affordable. These compact systems reduce the infrastructure and cost requirements of traditional particle therapy facilities, enabling more hospitals and cancer centers to adopt this advanced technology. Additionally, innovations like intensity-modulated proton therapy and adaptive treatment planning have enhanced the precision and adaptability of particle therapy, increasing its effectiveness across a broader range of cancer types. As technology continues to improve, particle therapy is becoming more viable for a wider range of healthcare facilities, expanding patient access and fueling market growth.

The expansion of particle therapy centers, particularly in regions like North America, Europe, and Asia-Pacific, is another significant factor in market growth. Governments and healthcare organizations are investing in particle therapy infrastructure, recognizing its benefits for cancer care and the potential for long-term healthcare cost savings. Many countries are also offering reimbursement and funding support to make particle therapy more accessible to patients. As more particle therapy centers are established globally, the availability and awareness of this treatment are increasing, driving further demand. Together, these factors—rising cancer incidence, demand for precise treatments, technological advancements, and infrastructure expansion—are driving robust growth in the particle therapy market, positioning it as a crucial component of modern oncology and personalized cancer care.

SCOPE OF STUDY:

The report analyzes the Particle Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Proton Therapy, Heavy Ion Therapy); System (Multi-Room Systems, Single-Room Systems); Application (Treatment, Research)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 22 Featured) -

  • Accuray Incorporated
  • Advanced Oncotherapy
  • Brainlab
  • Danfysik A/S
  • Elekta AB
  • Hitachi Ltd.
  • IBA Worldwide
  • Koninklijke Philips N.V.
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • Optivus Proton Therapy Inc.
  • Panacea
  • ProTom International
  • Provision Healthcare
  • PTW Freiburg GmbH
  • SAH Global LLC
  • Shinva Medical Instrument Co. Ltd
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems Inc.
  • xstrahl

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Particle Therapy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Drives Demand for Particle Therapy Solutions
    • Advancements in Proton Therapy Technologies Propel Particle Therapy Market
    • Increasing Adoption of Carbon Ion Therapy Expands Addressable Market
    • Growing Focus on Minimally Invasive Cancer Treatments Sets the Stage for Market Expansion
    • Innovations in Beam Delivery Systems Propel Particle Therapy Adoption
    • Demand for Pediatric Cancer Treatments Expands Particle Therapy Applications
    • Growing Awareness About Particle Therapy in Developing Economies Bodes Well for Market Growth
    • Increasing Use in Recurrent Tumor Treatments Sets the Stage for Market Growth
    • Demand for Proton Beam Therapy in Brain and Lung Cancers Spurs Adoption
    • Increasing Use in Proton Therapy for Prostate Cancer Sets the Stage for Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Particle Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Particle Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Particle Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Proton Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Heavy Ion Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Heavy Ion Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Heavy Ion Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Multi-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Multi-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Multi-Room Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Single-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Single-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Single-Room Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Particle Therapy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • JAPAN
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • CHINA
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • EUROPE
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Particle Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Particle Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Particle Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • FRANCE
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • GERMANY
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Italy 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: UK 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 125: Rest of World Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of World Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of World 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of World 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of World 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030

IV. COMPETITION